Currently no treatment option is available for five percent of patients suffering
from chronic myelogenous leukemia, since they have developed resistance to conventional medications.
Not exact matches
Chronic myelogenous leukemia (CML) is a human disease associated with a consistent chromosomal translocation that results in sequences
from the c - abl locus on chromosome 9 being fused to sequences in a breakpoint cluster region (bcr) on chromosome 22.
New treatment strategies to overcome drug resistance in
chronic myelogenous leukemia and other cancers will come
from the detailed structure of the enzyme Abl.